Prior Authorization Outsourcing for Infectious Disease and Infusion Practices

Responsibility for obtaining preauthorization is usually assigned by the practice’s internal workflow and payer requirements. It may involve front-office staff, authorization specialists, clinical staff, billing personnel, or an outsourced partner. The important control is clear ownership from eligibility and benefit verification through submission, follow-up, approval documentation, and communication with the care team. Practices should define responsibilities rather than assume authorization will happen automatically.

Prior authorization outsourcing can include eligibility and benefit verification, determining whether therapy falls under the medical or pharmacy benefit, preparing and submitting requests, tracking payer responses, documenting status, and coordinating follow-up. For infectious disease and infusion practices, workflows may involve infusions, OPAT courses, and specialty drugs. The exact activities should be defined so clinical, administrative, and billing teams know what the outsourced partner handles.

Benefit verification helps establish whether the patient is eligible and how the therapy is covered before the practice commits resources. It can also clarify whether an infusion or specialty drug falls under the medical or pharmacy benefit. That distinction affects the authorization pathway, documentation, billing workflow, and potential reimbursement risk. Verification should be documented and connected to the authorization record.

Requirements vary by payer and therapy, but an authorization request commonly depends on accurate patient and coverage information, the requested therapy, relevant clinical documentation, and details supporting medical necessity. Infusion and OPAT workflows may also require information that connects the treatment plan to the administration and drug claims. The practice should follow the payer’s stated requirements and retain the submitted materials and response.

Authorization problems can delay treatment decisions, create extra administrative work, and expose a practice to reimbursement risk. In a buy-and-bill environment, an unresolved authorization issue may affect payment for both the drug and its administration. Tracking each request, identifying benefit responsibility, and linking authorization status to scheduling and billing helps the practice identify issues before they become unreimbursed claims.

Yes. Authorization-related denial support may include reviewing the denial reason, identifying whether the issue involved missing authorization, benefit confusion, coding, or documentation, and preparing a payer-specific response supported by clinical records. Denial findings should also be shared with clinical, coding, and front-office teams so recurring process problems can be addressed rather than handled only as isolated appeals.

Authorization support should connect with claims management because approval details, benefit type, therapy information, and documentation can affect claim submission and payment. A coordinated workflow helps the practice carry authorization information into charge entry, coding review, claim scrubbing, submission, rejection clearing, and follow-up. This is particularly important when a practice bills both infusion services and drug claims.

A practice can evaluate its workflow by documenting each stage from referral and eligibility verification through authorization submission, decision, scheduling, billing, and follow-up. Review where requests stall, which information is repeatedly missing, whether medical and pharmacy benefits are being distinguished correctly, and how authorization issues appear in denials or aging A/R. The findings can guide a prioritized plan for internal improvement or outsourcing.